Pediatric Exclusivity, Richard Pazdur, MD, FDA ppt htm

Eloxatin (oxaliplatin), FDA Presentation ppt htm

Camptosar (irinotecan), FDA Presentation ppt htm

The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document

Eloxatin (oxaliplatin), Sponsor Presentation pdf

Camptosar (irinotecan), Sponsor Presentation ppt htm